Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer

FASEB Journal

Volumn 27, Issue 1, 2013, Pages 45-50

  Yang, Jiang ^a,b   McNeish, Brendan ^a   Butterfield, Catherine ^a   Moses, Marsha A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Extracellular signal regulated kinase; Hypoxia inducible factor 1 ; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIPOCALINS; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871892649     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-211730     Document Type: Article

References (29)

1. Yang, J., and Moses, M. A. (2009) Lipocalin 2: a multifaceted modulator of human cancer. Cell Cycle 8, 2347-2352
2. Gruvberger, S., Ringner, M., Chen, Y., Panavally, S., Saal, L. H., Borg, A., Ferno, M., Peterson, C., and Meltzer, P. S. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61, 5979-5984 (Pubitemid 32762524)
3. Bauer, M., Eickhoff, J. C., Gould, M. N., Mundhenke, C., Maass, N., and Friedl, A. (2008) Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res. Treat. 108, 389-397 (Pubitemid 351431077)
4. Yang, J., Bielenberg, D. R., Rodig, S. J., Doiron, R., Clifton, M. C., Kung, A. L., Strong, R. K., Zurakowski, D., and Moses, M. A. (2009) Lipocalin 2 promotes breast cancer progression. Proc. Natl. Acad. Sci. U. S. A. 106, 3913-3918
5. Hu, L., Hittelman, W., Lu, T., Ji, P., Arlinghaus, R., Shmulevich, I., Hamilton, S. R., and Zhang, W. (2009) NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab. Invest. 89, 531-548
6. Iannetti, A., Pacifico, F., Acquaviva, R., Lavorgna, A., Crescenzi, E., Vascotto, C., Tell, G., Salzano, A. M., Scaloni, A., Vuttariello, E., Chiappetta, G., Formisano, S., and Leonardi, A. (2008) The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl. Acad. Sci. U. S. A. 105, 14058-14063
7. Tong, Z., Wu, X., Ovcharenko, D., Zhu, J., Chen, C. S., and Kehrer, J. P. (2005) Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem. J. 391, 441-448 (Pubitemid 41532443)
8. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186
9. Harper, J., and Moses, M. A. (2006) Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications. EXS 96, 223-268
10. Fernandez, C. A., Yan, L., Louis, G., Yang, J., Kutok, J. L., and Moses, M. A. (2005) The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin. Cancer Res. 11, 5390-5395 (Pubitemid 41060812)
11. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (Pubitemid 24324921)
12. Moses, M. A., Wiederschain, D., Wu, I., Fernandez, C. A., Ghazizadeh, V., Lane, W. S., Flynn, E., Sytkowski, A., Tao, T., and Langer, R. (1999) Troponin I is present in human cartilage and inhibits angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 96, 2645-2650 (Pubitemid 29148771)
13. Fernandez, C. A., Butterfield, C., Jackson, G., and Moses, M. A. (2003) Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor. J. Biol. Chem. 278, 40989-40995 (Pubitemid 37280921)
14. Naumov, G. N., Bender, E., Zurakowski, D., Kang, S. Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., and Almog, N. (2006) A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J. Natl. Cancer Inst. 98, 316-325 (Pubitemid 43338211)
15. Ke, Q., and Costa, M. (2006) Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70, 1469-1480
16. Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., and Semenza, G. L. (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205-38211 (Pubitemid 35154674)
17. Yan, L., Borregaard, N., Kjeldsen, L., and Moses, M. A. (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276, 37258-37265
18. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J. P., Tong, F., Speed, T., Spellman, P. T., DeVries, S., Lapuk, A., Wang, N. J., Kuo, W. L., Stilwell, J. L., Pinkel, D., Albertson, D. G., Waldman, F. M., McCormick, F., Dickson, R. B., Johnson, M. D., Lippman, M., Ethier, S., Gazdar, A., and Gray, J. W. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 10, 515-527 (Pubitemid 44854747)
19. Leng, X., Ding, T., Lin, H., Wang, Y., Hu, L., Hu, J., Feig, B., Zhang, W., Pusztai, L., Symmans, W. F., Wu, Y., and Arlinghaus, R. B. (2009) Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res. 69, 8579-8584
20. Berger, T., Cheung, C. C., Elia, A. J., and Mak, T. W. (2010) Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis. Proc. Natl. Acad. Sci. U. S. A. 107, 2995-3000
21. Venkatesha, S., Hanai, J., Seth, P., Karumanchi, S. A., and Sukhatme, V. P. (2006) Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells. Mol. Cancer Res. 4, 821-829 (Pubitemid 44877012)
22. Kozma, S. C., Bogaard, M. E., Buser, K., Saurer, S. M., Bos, J. L., Groner, B., and Hynes, N. E. (1987) The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. Nucleic Acids Res. 15, 5963-5971
23. Hollestelle, A., Elstrodt, F., Nagel, J. H., Kallemeijn, W. W., and Schutte, M. (2007) Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol. Cancer Res. 5, 195-201 (Pubitemid 46424000)
24. Klausen, P., Niemann, C. U., Cowland, J. B., Krabbe, K., and Borregaard, N. (2005) On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response. Eur. J. Haematol. 75, 332-340 (Pubitemid 41297610)
25. Tong, Z., Kunnumakkara, A. B., Wang, H., Matsuo, Y., Diagaradjane, P., Harikumar, K. B., Ramachandran, V., Sung, B., Chakraborty, A., Bresalier, R. S., Logsdon, C., Aggarwal, B. B., Krishnan, S., and Guha, S. (2008) Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 68, 6100-6108
26. Moniaux, N., Chakraborty, S., Yalniz, M., Gonzalez, J., Shostrom, V. K., Standop, J., Lele, S. M., Ouellette, M., Pour, P. M., Sasson, A. R., Brand, R. E., Hollingsworth, M. A., Jain, M., and Batra, S. K. (2008) Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br. J. Cancer 98, 1540-1547 (Pubitemid 351652327)
27. Ebrahem, Q., Chaurasia, S. S., Vasanji, A., Qi, J. H., Klenotic, P. A., Cutler, A., Asosingh, K., Erzurum, S., and Anand-Apte, B. (2010) Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am. J. Pathol. 176, 496-503
28. Roy, R., Zhang, B., and Moses, M. A. (2006) Making the cut: protease-mediated regulation of angiogenesis. Exp. Cell Res. 312, 608-622 (Pubitemid 43290337)
29. Roy, R., Yang, J., and Moses, M. A. (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 27, 5287-5297